Digital Therapeutics Market By Application (Diabetes, Obesity, CVD, CNS Disease, Respiratory Diseases, Smoking Cessation), By End-use (Patients, Providers, Payers, Employers)- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2021-2027

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Digital Therapeutics Market, By End-Use

7.1.  Digital Therapeutics Market, By End-Use Type, 2020-2027

7.1.1.    Diabetes

7.1.1.1.        Market Revenue and Forecast (2016-2027)

7.1.2.    Obesity

7.1.2.1.        Market Revenue and Forecast (2016-2027)

7.1.3.    CVD

7.1.3.1.        Market Revenue and Forecast (2016-2027)

7.1.4.    Polyethylene

7.1.4.1.        Market Revenue and Forecast (2016-2027)

7.1.5.    CNS Disease

7.1.5.1.        Market Revenue and Forecast (2016-2027)

7.1.6.    Respiratory Diseases

7.1.6.1.        Market Revenue and Forecast (2016-2027)

7.1.7.    Smoking Cessation

7.1.7.1.        Market Revenue and Forecast (2016-2027)

7.1.8.    Others

7.1.8.1.        Market Revenue and Forecast (2016-2027)

Chapter 8.  Global Digital Therapeutics Market, By End-Use

8.1.  Digital Therapeutics Market, By End-Use, 2020-2027

8.1.1.    Patients

8.1.1.1.        Market Revenue and Forecast (2016-2027)

8.1.2.    Providers

8.1.2.1.        Market Revenue and Forecast (2016-2027)

8.1.3.    Payers

8.1.3.1.        Market Revenue and Forecast (2016-2027)

8.1.4.    Employers

8.1.4.1.        Market Revenue and Forecast (2016-2027)

8.1.5.    Others

8.1.5.1.        Market Revenue and Forecast (2016-2027)

Chapter 9.  Global Digital Therapeutics Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, By End-Use (2016-2027)

9.1.2.    Market Revenue and Forecast, By End-Use (2016-2027)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, By End-Use (2016-2027)

9.1.3.2.        Market Revenue and Forecast, By End-Use (2016-2027)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, By End-Use (2016-2027)

9.1.4.2.        Market Revenue and Forecast, By End-Use (2016-2027)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, By End-Use (2016-2027)

9.2.2.    Market Revenue and Forecast, By End-Use (2016-2027)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, By End-Use (2016-2027)

9.2.3.2.        Market Revenue and Forecast, By End-Use (2016-2027)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, By End-Use (2016-2027)

9.2.4.2.        Market Revenue and Forecast, By End-Use (2016-2027)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, By End-Use (2016-2027)

9.2.5.2.        Market Revenue and Forecast, By End-Use (2016-2027)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, By End-Use (2016-2027)

9.2.6.2.        Market Revenue and Forecast, By End-Use (2016-2027)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, By End-Use (2016-2027)

9.3.2.    Market Revenue and Forecast, By End-Use (2016-2027)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, By End-Use (2016-2027)

9.3.3.2.        Market Revenue and Forecast, By End-Use (2016-2027)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, By End-Use (2016-2027)

9.3.4.2.        Market Revenue and Forecast, By End-Use (2016-2027)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, By End-Use (2016-2027)

9.3.5.2.        Market Revenue and Forecast, By End-Use (2016-2027)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, By End-Use (2016-2027)

9.3.6.2.        Market Revenue and Forecast, By End-Use (2016-2027)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, By End-Use (2016-2027)

9.4.2.    Market Revenue and Forecast, By End-Use (2016-2027)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, By End-Use (2016-2027)

9.4.3.2.        Market Revenue and Forecast, By End-Use (2016-2027)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, By End-Use (2016-2027)

9.4.4.2.        Market Revenue and Forecast, By End-Use (2016-2027)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, By End-Use (2016-2027)

9.4.5.2.        Market Revenue and Forecast, By End-Use (2016-2027)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, By End-Use (2016-2027)

9.4.6.2.        Market Revenue and Forecast, By End-Use (2016-2027)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, By End-Use (2016-2027)

9.5.2.    Market Revenue and Forecast, By End-Use (2016-2027)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, By End-Use (2016-2027)

9.5.3.2.        Market Revenue and Forecast, By End-Use (2016-2027)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, By End-Use (2016-2027)

9.5.4.2.        Market Revenue and Forecast, By End-Use (2016-2027)

Chapter 10.  Company Profiles

10.1.              Omada Health, Inc.

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              WellDoc, Inc.

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              2Morrow, Inc.

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              Livongo Health

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              Propeller Health

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              Pear Therapeutics

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              Twine Health, Inc.

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              Canary Health, Inc.

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.              Noom Health, Inc.

10.9.1.  Company Overview

10.9.2.  Product Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

10.10.           Mango Health, Inc.

10.10.1.               Company Overview

10.10.2.               Product Offerings

10.10.3.               Financial Performance

10.10.4.               Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

Glossary of Terms